BioMarin Pharmaceutical | 営業利益



Operating Profit 変化する 日付
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 2.31B 182M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
Incyte USD 301.51M 155.43M 2024-12
Insmed USD -230414000 16.98M 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
PTC Therapeutics USD -62489000 7.98M 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 3.64B 1.35B 2024-09
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



BioMarin Pharmaceutical 営業利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2025.